Mylan Investors

As one of the world’s leading generics and specialty pharmaceutical companies, our products reach approximately 145 countries and territories. Our leading position in key global markets is based on a broad product portfolio, robust pipeline, approximately 30,000 workforce, wide range of dosage forms and delivery systems, large manufacturing capacity and dedication to quality and service.

2015.10.02, 4:00 PM ET

MYL Last Trade




Daily High


Daily Low


Daily Volume


Mylan will provide shareholders, upon request, a hard copy of its latest 10-K free of charge.

Get the latest from Mylan
Sign up for email alerts

Upcoming Events

Past Events

Event Default

Morgan Stanley Global Healthcare Conference

September 17, 2015 | 4:40 PM EDT

The Grand Hyatt New York

New York | NY

Event Default

Second Quarter 2015 Financial Results

Aug 06, 2015 10:00 AM ET

Listen to Webcast


Meet our passionate global leaders.